BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haro KJ, Scott AC, Scheinberg DA. Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells. Blood 2012;120:2087-97. [PMID: 22829630 DOI: 10.1182/blood-2012-01-404509] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wickstroem K, Karlsson J, Ellingsen C, Cruciani V, Kristian A, Hagemann UB, Bjerke RM, Ryan OB, Linden L, Mumberg D, Brands M, Cuthbertson A. Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model. Pharmaceuticals (Basel) 2019;12:E155. [PMID: 31618864 DOI: 10.3390/ph12040155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
2 Cortez A, Josefsson A, McCarty G, Shtekler AE, Rao A, Austin Z, Nedrow JR. Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma. Nucl Med Biol 2020;88-89:62-72. [PMID: 32799049 DOI: 10.1016/j.nucmedbio.2020.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Palanca-Wessels MC, Press OW. Advances in the treatment of hematologic malignancies using immunoconjugates. Blood 2014;123:2293-301. [PMID: 24578502 DOI: 10.1182/blood-2013-10-492223] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
4 Seidl C. Radioimmunotherapy with α-particle-emitting radionuclides. Immunotherapy 2014;6:431-58. [DOI: 10.2217/imt.14.16] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
5 Iordanskiy S, Van Duyne R, Sampey GC, Woodson CM, Fry K, Saifuddin M, Guo J, Wu Y, Romerio F, Kashanchi F. Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells. Virology 2015;485:1-15. [PMID: 26184775 DOI: 10.1016/j.virol.2015.06.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
6 Graf F, Fahrer J, Maus S, Morgenstern A, Bruchertseifer F, Venkatachalam S, Fottner C, Weber MM, Huelsenbeck J, Schreckenberger M, Kaina B, Miederer M. DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy. PLoS One 2014;9:e88239. [PMID: 24516620 DOI: 10.1371/journal.pone.0088239] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
7 Sgouros G. Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters. Semin Nucl Med 2020;50:124-32. [PMID: 32172797 DOI: 10.1053/j.semnuclmed.2019.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
8 Karimian A, Ji NT, Song H, Sgouros G. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy. Cancer Res 2020;80:868-76. [PMID: 31772036 DOI: 10.1158/0008-5472.CAN-19-2553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Wickstroem K, Hagemann UB, Cruciani V, Wengner AM, Kristian A, Ellingsen C, Siemeister G, Bjerke RM, Karlsson J, Ryan OB, Linden L, Mumberg D, Ziegelbauer K, Cuthbertson AS. Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models. J Nucl Med 2019;60:1293-300. [PMID: 30850485 DOI: 10.2967/jnumed.118.223701] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
10 King AP, Lin FI, Escorcia FE. Why bother with alpha particles? Eur J Nucl Med Mol Imaging 2021. [PMID: 34175980 DOI: 10.1007/s00259-021-05431-y] [Reference Citation Analysis]
11 O'Steen S, Comstock ML, Orozco JJ, Hamlin DK, Wilbur DS, Jones JC, Kenoyer A, Nartea ME, Lin Y, Miller BW, Gooley TA, Tuazon SA, Till BG, Gopal AK, Sandmaier BM, Press OW, Green DJ. The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model. Blood 2019;134:1247-56. [PMID: 31395601 DOI: 10.1182/blood.2019001250] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wickstroem K, Hagemann UB, Kristian A, Ellingsen C, Sommer A, Ellinger-ziegelbauer H, Wirnitzer U, Hagelin E, Larsen A, Smeets R, Bjerke RM, Karlsson J, Ryan OB, Wengner AM, Linden L, Mumberg D, Cuthbertson AS. Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344. International Journal of Radiation Oncology*Biology*Physics 2019;105:410-22. [DOI: 10.1016/j.ijrobp.2019.06.2508] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
13 Toro-gonzález M, Dame AN, Mirzadeh S, Rojas JV. Encapsulation and retention of 225 Ac, 223 Ra, 227 Th, and decay daughters in zircon-type gadolinium vanadate nanoparticles. Radiochimica Acta 2020;108:967-77. [DOI: 10.1515/ract-2019-3206] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yard BD, Gopal P, Bannik K, Siemeister G, Hagemann UB, Abazeed ME. Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation. Cancer Res 2019;79:5640-51. [PMID: 31387923 DOI: 10.1158/0008-5472.CAN-19-0859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Baidoo KE, Yong K, Brechbiel MW. Molecular pathways: targeted α-particle radiation therapy. Clin Cancer Res 2013;19:530-7. [PMID: 23230321 DOI: 10.1158/1078-0432.CCR-12-0298] [Cited by in Crossref: 100] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
16 Monzen S, Chiba M, Ueno T, Morino Y, Terada K, Yamaya H, Hosokawa Y. A radioresistant fraction of acute promyelocytic leukemia cells exhibit CD38 cell-surface antigen and mRNA expression. Oncol Lett 2018;15:6709-14. [PMID: 29616132 DOI: 10.3892/ol.2018.8099] [Reference Citation Analysis]
17 Li X, Chen F, Zhu Q, Ding B, Zhong Q, Huang K, Jiang X, Wang Z, Yin C, Zhu Y, Li Z, Meng F. Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells. Oncotarget 2016;7:33004-15. [PMID: 27105509 DOI: 10.18632/oncotarget.8844] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]